Y-mAbs Therapeutics, Inc. - COM (YMAB)

Historical Portfolio Holders from Q3 2018 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
24.4M
Holdings value Q2 2024
$294M
Value change Q2 2024
+$14.9M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
95
Number of buys Q2 2024
49
Number of sells Q2 2024
-49
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 24.4M $294M +$14.9M $12.08 95
2024 Q1 23M $374M +$49.2M $16.26 94
2023 Q4 20.2M $138M +$5.3M $6.82 93
2023 Q3 19.7M $107M +$834K $5.45 98
2023 Q2 19.5M $132M +$4.6M $6.79 94
2023 Q1 19M $95.4M -$1.06M $5.01 84
2022 Q4 19.2M $93.6M -$55.2M $4.88 88
2022 Q3 23.4M $338M -$16.2M $14.42 94
2022 Q2 24.8M $375M -$7.97M $15.13 90
2022 Q1 22.4M $266M -$16.7M $11.88 85
2021 Q4 25.7M $416M -$15M $16.21 92
2021 Q3 26.2M $748M -$938K $28.54 95
2021 Q2 26.1M $883M -$4.43M $33.80 98
2021 Q1 26.3M $796M +$116M $30.24 115
2020 Q4 22.6M $1.12B +$38.1M $49.51 113
2020 Q3 21.3M $816M +$2.34M $38.39 105
2020 Q2 20.9M $905M +$48.4M $43.20 107
2020 Q1 20M $520M +$16.1M $26.10 77
2019 Q4 19.4M $606M +$185M $31.25 80
2019 Q3 13.1M $341M +$56.1M $26.06 63
2019 Q2 11M $251M +$54.2M $22.87 59
2019 Q1 8.47M $222M -$3.28M $26.21 43
2018 Q4 8.69M $176M +$18.7M $20.34 42
2018 Q3 7.73M $204M +$204M $26.56 38